Free Trial
OTCMKTS:GTHP

Guided Therapeutics (GTHP) Stock Price, News & Analysis

Guided Therapeutics logo
$0.19 +0.01 (+5.71%)
(As of 11/22/2024 ET)

About Guided Therapeutics Stock (OTCMKTS:GTHP)

Key Stats

Today's Range
$0.16
$0.19
50-Day Range
$0.12
$0.20
52-Week Range
$0.06
$0.25
Volume
5,400 shs
Average Volume
21,127 shs
Market Capitalization
$11.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Receive GTHP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GTHP Stock News Headlines

Guided Therapeutics (GTHP) & The Competition Head-To-Head Analysis
Fed Declares War on Americans
Fed Declares War on Americans Protect your wealth in the coming months…
Guided Therapeutics Inc (GTHP)
See More Headlines

GTHP Stock Analysis - Frequently Asked Questions

Guided Therapeutics' stock was trading at $0.1535 at the beginning of 2024. Since then, GTHP stock has increased by 20.5% and is now trading at $0.1850.
View the best growth stocks for 2024 here
.

Shares of GTHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guided Therapeutics investors own include Cornerstone Strategic Value Fund (CLM), Intel (INTC), Beam Therapeutics (BEAM), ChargePoint (CHPT), CSX (CSX), Warner Bros. Discovery (DISCA) and Enbridge (ENB).

Company Calendar

Today
11/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:GTHP
Employees
5
Year Founded
N/A

Profitability

Net Income
$-3,490,000.00
Pretax Margin
-5,660.53%

Debt

Sales & Book Value

Annual Sales
$100,000.00
Book Value
($0.13) per share

Miscellaneous

Free Float
20,239,000
Market Cap
$11.29 million
Optionable
Not Optionable
Beta
0.51
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (OTCMKTS:GTHP) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners